oleanolic acid has been researched along with ribavirin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Kumada, H; Tsubota, A | 1 |
| Imazeki, F | 1 |
| Yamada, G | 1 |
3 review(s) available for oleanolic acid and ribavirin
| Article | Year |
|---|---|
[Therapeutic strategies for hepatitis C].
Topics: Antiviral Agents; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Interferons; Oleanolic Acid; Pharmacogenetics; Phlebotomy; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Ursodeoxycholic Acid | 2004 |
[Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Iron, Dietary; Liver Neoplasms; Oleanolic Acid; Phlebotomy; Prognosis; Ribavirin; Time Factors | 2004 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
1 other study(ies) available for oleanolic acid and ribavirin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |